We are Sorry, This Page doesn't Exist
FDA approves Bristol-Myers combo for metastatic non-small cell lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Medal of Honor recipient diagnosed with lung cancer gives a sobering message on treatment after being unconscious for a week
Instagram Former US Army Staff Sgt. Ronald Shurer, who received a Medal of Honor for his heroism in Afghanistan, is undergoing lung cancer treatment. "Very upset to write th.....»»
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) read more.....»»
UroGen shares jump 10% on FDA approval of rare cancer treatment
Shares of UroGen Pharma Ltd. gained 10.7% in .....»»
UruGen shares jump 10% on FDA approval of rare cancer treatment
Shares of UroGen Pharma Ltd. gained 10.7% in .....»»
Bristol-Myers: Japan"s MHLW approves Opdivo for treatment of esophageal cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Margin: Rush Limbaugh says he has advanced lung cancer, vows to keep doing his show
Conservative lightning rod Rush Limbaugh told listeners on Monday that he has “advanced lung cancer†and will be missing shows for treatment......»»
FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from........»»
Intrexon will take the name of its subsidiary. That company just scored orphan status for a rare cancer drug.
Just four days after Intrexon Corp. (NASDAQ: XON) made public plans to rebrand as Precigen, its subsidiary by the same name has secured a coveted regulatory designation for its blood cancer treatment. Germantown’s Precigen Inc. has earned orpha.....»»
Spectrum Pharmaceuticals shares slide 57% after lung cancer trial misses goals
Shares of biopharmaceutical company Spectrum Pharmaceuticals Inc. slid more than 57% Thursday to mark their worst performance in 17 years, after the company said a mid-stage trial of a treatment for non-small cell lung cancer (NSCLC) missed its main goal......»»
UPDATE: Spectrum Pharma shares slide 47% premarket after trial of lung cancer treatment misses main goal
Spectrum Pharmaceuticals Inc. shares fell 47% in premarket trade Thursday after the company said a mid-stage trial of a treatment for non-small cell lung cancer, or NSCLC, missed its main goal. The Henderson, Nevada-bas.....»»
Spectrum Pharma shares slide 17% premarket after trial of lung cancer treatment misses main goal
Spectrum Pharmaceuticals Inc. shares fell 17% in premarket trade Thursday after the company said a mid-stage trial of a treatment for non-small cell lung cancer, or NSCLC, missed its main goal. The Henderson, Nevada-bas.....»»
FDA approves new treatment option for HER2-positive breast cancer patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amgen granted orphan status for small cell lung cancer treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
In an about face, FDA approves Sarepta"s 2nd Duchenne drug
The FDA unexpectedly reversed course Thursday, approving the second treatment developed by Sarepta Therapeutics for the rare disease Duchenne muscular dystrophy just a few months after rejecting the drug. Sarepta (Nasdaq: SRPT) announced Thursday even.....»»
A 17-year-old vaped so much he needed a double-lung transplant, a last resort when all other treatments fail
Jane Khomi / Getty Images An unnamed 17-year-old in Detroit recently became the first person to need a double-lung transplant due to a vaping-related lung injury. The case, while frightening, is a rare last-resort treatment fo.....»»
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Merck KGaA and Pfizer said Friday that a late-stage clinical trial testing Bavencio as a first-line maintenance treatment for patients with certain forms of gastric cancer failed to meet the study's primary endpoints for survival. The cur.....»»
Eli Lilly Throws Hat In The Ring For Lung Cancer Space, Takes Targeted Treatment Approach
Eli Lilly Throws Hat In The Ring For Lung Cancer Space, Takes Targeted Treatment Approach.....»»
Surprising Reaction to Lung Cancer Study Results
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer......»»
AstraZeneca"s Imfinzi Gains Orphan Drug Status for SCLC
The FDA assigns an orphan drug designation to AstraZeneca's (AZN) Imfinzi for the treatment of small cell lung cancer, the mo.....»»